Management of Antiphospholipid Syndrome in Pregnancy

Rheumatic Disease Clinics of North America

Volumn 32, Issue 3, 2006, Pages 591-607

  Petri, Michelle ^a   Qazi, Umair ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLEEDING; CLINICAL TRIAL; DELIVERY; FETUS WASTAGE; HUMAN; HYPERCOAGULABILITY; MATERNAL MORBIDITY; MOTHER; NONHUMAN; OSTEOPOROSIS; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; THROMBOCYTOPENIA; THROMBOSIS; THROMBOSIS PREVENTION; UTERUS; VEIN DILATATION; VEIN THROMBOSIS; VENOUS STASIS;

ABORTION, HABITUAL; ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOSIS;

EID: 33746630917     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2006.05.007     Document Type: Review

References (46)

1. Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 81 (1997) 151-178
2. Ruiz-Irastorza G., Khamashta M.A., and Hughes G.R. Hughes syndrome crosses boundaries. Autoimmun Rev 1 (2002) 43-48
3. Khamashta M.A., Cuadrado M.J., Mujic F., et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 332 (1995) 993-997
4. Holers V.M., Girardi G., Mo L., et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195 2 (2002) 211-220
5. Girardi G., Redecha P., and Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10 11 (2004) 1222-1226
6. Di Simone N., Meroni P.L., de Papa N., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 43 1 (2000) 140-150
7. Shoenfeld Y., Sherer Y., and Fishman P. Interleukin-3 and pregnancy loss in antiphospholipid syndrome. Scand J Rheumatol Suppl 107 (1998) 19-22
8. Rand J.H., Wu X.X., Andree H.A.M., et al. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N Engl J Med 337 3 (1997) 154-160
9. Tulppala M., Marttunen M., Soderstrom-Anttila V., et al. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 12 7 (1997) 1567-1572
10. Cowchock S., and Reece E.A. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial. Am J Obstet Gynecol 176 5 (1997) 1099-1100
11. Pattison N.S., Chamley L.W., Birdsall M., et al. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol 183 4 (2000) 1008-1012
12. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174 (1996) 1584-1589
13. Rai R., Cohen H., Dave M., et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314 7076 (1997) 253-257
14. Farquharson R.G., Quenby S., and Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100 3 (2002) 408-413
15. Cowchock F.S., Reece E.A., Balaban D., et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166 (1992) 1318-1323
16. Dahlman T.C. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 168 4 (1993) 1265-1270
17. de Swiet M., Ward P.D., Fidler J., et al. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynaecol 90 12 (1983) 1129-1134
18. Nelson-Piercy C. Low molecular weight heparin for prophylaxis of thromboembolic disease during pregnancy. In: Gamer P., and Lee R. (Eds). Current obstetric medicine (1995), Mosby, St. Louis (MO) 147-158
19. Auger W.R., Permpikul P., and Moser K.M. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am J Med 99 (1995) 392-396
20. Gruel Y., Rupin A., Watier H., et al. Anticardiolipin antibodies in heparin-associated thrombocytopenia. Thromb Res 67 (1992) 601-606
21. Langford K., and Nelson-Piercy C. Antiphospholipid syndrome in pregnancy. Contemp Rev Obstet Gynecol 11 (1999) 93-98
22. Ensom M.H., and Stephenson M.D. Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy. J Soc Gynecol Investig 11 6 (2004) 377-383
23. Stephenson M.D., Ballem P.J., Tsang P., et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 26 8 (2004) 729-734
24. Noble L.S., Kutteh W.H., Lashey N., et al. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 83 3 (2005) 684-690
25. Pauzner R., Dulitzki M., Langevitz P., et al. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 86 6 (2001) 1379-1384
26. Pierangeli S.S., Espinola R., Liu X., et al. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum 44 4 (2001) 876-883
27. Branch D.W., Peaceman A.M., Druzin M., et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 182 1 Pt 1 (2000) 122-127
28. Jeremic K., Pervulov M., Gojnic M., et al. Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Vojnosanit Pregl 62 6 (2005) 435-439
29. Lubbe W.F., Butler W.S., Palmer S.J., et al. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1 (1983) 1361-1363
30. Silver R.K., MacGregor S.N., Sholl J.S., et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 169 6 (1993) 1411-1417
31. Laskin C.A., Bombardier C., Hannah M.E., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 337 (1997) 148-153
32. Rosove M.H., and Brewer P.M.C. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117 (1992) 303-308
33. Derksen R.H.W.M., de Groot P.G., Kater L., and Nieuwenhuis H.K. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 52 (1993) 689-692
34. Schulman S., Svenungsson E., Granqvist S., and and The Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patinets with venous thromboembolism following anticoagulant therapy. Am J Med 104 (1998) 332-338
35. Crowther M.A., Ginsberg J.S., Julian J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349 12 (2003) 1133-1138
36. Finazzi G., Marchioli R., Brancaccio V., et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 3 5 (2005) 848-853
37. Kalunian K.C., Peter J.B., Middlekauff H.R., et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 85 (1988) 602-608
38. Parke A.L. Antimalarial drugs, systemic lupus erythematosus and pregnancy. J Rheumatol 15 (1988) 607-610
39. Parke A., and West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 23 (1996) 1715-1718
40. Levy R.A., Vilela V.S., Cataldo M.J., et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10 (2001) 401-404
41. Espinola R.G., Pierangeli S.S., Gharavi A.E., et al. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost 87 3 (2002) 518-522
42. Edwards M.H., Pierangeli S., Liu X., et al. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 96 12 (1997) 4380-4384
43. Erkan D., Sammaritano L., Levy R., et al. APLASA Study 2004 update: primary thrombosis prevention in asymptomatic antiphospholipid antibody (APL) positive patients with low-dose aspirin (ASA). Arthritis Rheum 50 Suppl. 9 (2004) S640
44. Kutteh W.H., and Ermel L.D. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 35 4 (1996) 402-407
45. Triolo G., Ferrante A., Ciccia F., et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 48 3 (2003) 728-731
46. Malinowski A., Dynski M.A., Maciolek-Blewniewska G., et al. Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome. Ginekol Pol 74 10 (2003) 1213-1222